Danaher Drops $10B to Snatch Masimo in Diagnostics Push
• Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. • The move reflects a broader in
• Danaher is acquiring Masimo in a $10 billion deal aimed at expanding its diagnostics portfolio and deepening its presence in acute care settings. • The move reflects a broader in